Your browser doesn't support javascript.
loading
Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib.
Arslan, Shukaib; Ali, Haris; Mei, Mathew; Marcucci, Guido; Forman, Stephan; Nakamura, Ryotaro; Stein, Anthony; Al Malki, Monzr M.
Affiliation
  • Arslan S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA. sarslan@coh.org.
  • Ali H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Mei M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Forman S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Stein A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Al Malki MM; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
Bone Marrow Transplant ; 57(5): 830-833, 2022 05.
Article in En | MEDLINE | ID: mdl-35194155

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Red-Cell Aplasia, Pure / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies Limits: Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Red-Cell Aplasia, Pure / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies Limits: Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2022 Document type: Article Affiliation country: United States